Cent Eur J Public Health 2014, 22(1):29-33 | DOI: 10.21101/cejph.a3844

Prevalence of Viral Hepatitis in Croatian Adult Population Undergoing Routine Check-up, 2010-2011

Tatjana Vilibić-Čavlek1, Jasmina Kučinar2, Sunčanica Ljubin-Sternak2, Bernard Kaić3, Lorena Lazarić-Stefanović2, Branko Kolarić4,5
1 Virology Department, Croatian National Institute of Public Health and School of Medicine University of Zagreb, Zagreb, Croatia
2 Microbiology Department, Istria County Institute of Public Health, Pula, Croatia
3 Communicable Disease Epidemiology Service, Croatian National Institute of Public Health, Zagreb, Croatia
4 Public Health, Social Medicine and Gerontology Service, Zagreb County Institute of Public Health, Zagreb, Croatia
5 School of Medicine, University of Rijeka, Rijeka, Croatia

Seroprevalence data on viral hepatitis in the general population vary widely. The aim of this study was to determine the prevalence of hepatitis A (HAV), hepatitis B (HBV) and hepatitis C (HCV) viruses in the general Croatian adult population undergoing routine check-ups. The seroprevalence of anti-HAV, anti-HBc and anti-HCV was 40.5%, 7.0% and 0.9%, respectively. HBsAg was found in 0.7% and anti-HBs antibodies in 24.4% of participants. Gender was not associated with HAV, HBV or HCV seropositivity. HAV and HBV seropositivity increased progressively with age (HAV from 11.7% to 90.4%, p<0.001; HBV from 1.7% to 15.8%, p<0.001). Participants from rural areas showed a significantly higher HBV seroprevalence rate than those from urban areas (10.7% vs. 6.1%, p=0.007). Results of univariate and multiple logistic regression showed that older age was a significant predictor for both HAV and HBV seropositivity while rural place of residence was a significant predictor for HBV seropositivity.

Klíčová slova: HAV, HBV, HCV, seroprevalence, Croatia

Vloženo: 9. říjen 2012; Revidováno: 12. prosinec 2013; Přijato: 12. prosinec 2013; Zveřejněno: 1. březen 2014  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vilibić-Čavlek T, Kučinar J, Ljubin-Sternak S, Kaić B, Lazarić-Stefanović L, Kolarić B. Prevalence of Viral Hepatitis in Croatian Adult Population Undergoing Routine Check-up, 2010-2011. Cent Eur J Public Health. 2014;22(1):29-33. doi: 10.21101/cejph.a3844. PubMed PMID: 24844103.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, Cavaleri M, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference. J Viral Hepat. 2011 Sep;18 Suppl 1:1-16. Přejít k původnímu zdroji... Přejít na PubMed...
    2. Daniels D, Grytdal S, WasleyA; Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ. 2009 May 22;58(3):1-27.
    3. Bernard H, Frank C. Cluster of hepatitisAcases among travellers returning from Egypt, Germany, September through November 2008. Euro Surveill. 2009 Jan 22;14(3). pii: 19096. Přejít k původnímu zdroji...
    4. Petrignani M, Harms M, Verhoef L, van Hunen R, Swaan C, van Steenbergen J, et al. Update: a food-borne outbreak of hepatitis A in the Netherlands related to semi-dried tomatoes in oil, January-February 2010. Euro Surveill. 2010 May 20;15(20). pii: 19572. Přejít k původnímu zdroji...
    5. Gillesberg Lassen S, Soborg B, Midgley SE, Steens A, Vold L, SteneJohansen K, et al. Ongoing multi-strain food-borne hepatitis A outbreak with frozen berries as suspected vehicle: four Nordic countries affected, October 2012 to April 2013. Euro Surveill. 2013 Apr 25;18(17):20467. Přejít k původnímu zdroji... Přejít na PubMed...
    6. Mossong J, Putz L, Patiny S, Schneider F. Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg. Epidemiol Infect. 2006 Aug;134(4):808-13. Přejít k původnímu zdroji... Přejít na PubMed...
    7. Chlíbek R, Čečetková B, Smetana J, Prymula R, Kohl I. Seroprevalence of antibodies against hepatitisAvirus and hepatitis B virus in nonvaccinated adult population over 40 years of age. Epidemiol Mikrobiol Imunol. 2006 Aug;55(3):99-104. (In Czech.)
    8. Quaglio G, Ramadani N, Pattaro C, Cami A, Dentico P, Volpe A, et al. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol. 2008 May;80(5):833-40. Přejít k původnímu zdroji... Přejít na PubMed...
    9. Vatev NT,Atanasova MV, StoilovaYD, Chervenyakova TP, Troyancheva MG. Seroprevalence of hepatitis A viral infection in Plovdiv, Bulgaria. Folia Med (Plovdiv). 2009 Jan-Mar;51(1):70-3. Přejít na PubMed...
    10. Vilibic-Cavlek T, Kucinar J, Ljubin-Sternak S, Kolaric B. Seroepidemiology of hepatitis A in the Croatian population. Hepat Mon. 2011 Dec;11(12):997-9. Přejít k původnímu zdroji... Přejít na PubMed...
    11. Fabris P, Baldo V, Baldovin T, Bellotto E, Rassu M, Trivello R, et al. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol. 2008 MayJun;42(5):527-32. Přejít k původnímu zdroji... Přejít na PubMed...
    12. Baaten GG, Sonder GJ, Dukers NH, Coutinho RA, Van den Hoek JA. Population-based study on the seroprevalence of hepatitis A, B, and C virus infection inAmsterdam, 2004. J Med Virol. 2007 Dec;79(12):180210. Přejít k původnímu zdroji...
    13. Meffre C, Le Strat Y, Delarocque-Astagneau E, Dubois F, Antona D, Lemasson JM, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol. 2010 Apr;82(4):546-55. Přejít k původnímu zdroji... Přejít na PubMed...
    14. Zacharakis G, Kotsiou S, Papoutselis M, Vafiadis N, Tzara F, Pouliou E, et al. Changes in the epidemiology of hepatitis B virus infection following the implementation of immunisation programmes in northeastern Greece. Euro Surveill. 2009 Aug 13;14(32). pii: 19297. Přejít k původnímu zdroji...
    15. Cozzolongo R, Osella AR, Elba S, Petruzzi J, Buongiorno G, Giannuzzi V, et al.; NUTRIHEPCollaborating Group. Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol. 2009 Nov;104(11):2740-6. Přejít k původnímu zdroji... Přejít na PubMed...
    16. Voiculescu M, Iliescu L, Ionescu C, Micu L, Ismail G, Zilisteanu D, et al. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania. J Gastrointestin Liver Dis. 2010 Mar;19(1):43-8.
    17. Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol. 2003;18(6):551-7. Přejít k původnímu zdroji...
    18. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011 Aug 13;378(9791):571-83. Přejít k původnímu zdroji... Přejít na PubMed...
    19. Kolovrat A, Jurišić I, Marić Z, Cvitković A. Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia. Acta Med Croatica. 2010 Oct;64(4):287-96. (In Croatian.) Přejít na PubMed...
    20. Vilibić-Čavlek T, Marić J, Katičić L, Kolarić B. Hepatitis C virus antibody status, sociodemographic characteristics, and risk behaviour among injecting drug users in Croatia. Cent Eur J Public Health. 2011 Mar;19(1):26-9. Přejít k původnímu zdroji...
    21. Bosevska G, Kuzmanovska G, SikoleA, Dzekova-Vidimilski P, Polenakovic M. Screening for hepatitis B, C and HIV infection among patients on haemodialysis (cross sectional analysis among patients from two dialysis units in the period January to July 2005). Prilozi. 2009 Dec;30(2):159-74. Přejít na PubMed...
    22. Vilibic Cavlek T, Gjenero Margan I, Zidovec Lepej S, Kolaric B, Vince A. Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia. J Med Virol. 2009 Aug;81(8):1348-53. Přejít k původnímu zdroji... Přejít na PubMed...
    23. Grgičević D, Balija M, Pirc-Tiljak D, Mihaljević I, Gjenero-Margan I, Zupančić-Šalek S, et al. Decreasing risk of viral transfusion-transmitted diseases in Croatia. Croat Med J. 2000 Jun;41(2):191-6. Přejít na PubMed...
    24. Kolarić B, Štajduhar D, Gajnik D, Rukavina T, Wiessing L. Seroprevalence of blood-borne infections and population sizes estimates in a population of injecting drug users in Croatia. Cent Eur J Public Health. 2010 Jun;18(2):104-9. Přejít k původnímu zdroji...
    25. Jelić O, Jelić D, Balen I, Jelić A, Jelić N, Mihaljević I. Prevalence of markers of hepatitis B virus infection among the general population of the municipality of Slavonski Brod. Acta Med Croatica. 1994;48(3):111-6. Přejít na PubMed...
    26. Medić A, Dželalija B, Sonicki Z, Zekanović D. Characteristics of hepatitis C infection in injecting drug users in Zadar County, Croatia. Coll Antropol. 2008 Sep;32(3):697-702. Přejít na PubMed...
    27. Bozicevic I, Dakovic Rode O, Zidovec Lepej S, Johnston LG, Stulhofer A, Dominkovic Z, et al. Prevalence of sexually transmitted infections among men who have sex with men in Zagreb, Croatia. AIDS Behav. 2009 Apr;13(2):303-9. Přejít k původnímu zdroji... Přejít na PubMed...
    28. Burek V, Horvat J, Butorac K, Mikulić R. Viral hepatitis B, C and HIV infection in Croatian prisons. Epidemiol Infect. 2010 Nov;138(11):161020. Přejít k původnímu zdroji... Přejít na PubMed...
    29. Vilibic-Cavlek T, Gjenero-Margan I, Retkovac B, Kolaric B, Bisko A, Banozic-Blagus Z, et al. Sociodemographic characteristics and risk behaviors for HIV, hepatitis B and hepatitis C virus infection among Croatian male prisoners. Int J Prison Health. 2011;7(1):28-31.
    30. Domínguez A, Bruguera M, Plans P, Espuñes J, Costa J, Plasencia A, et al. Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study. BMC Infect Dis. 2007 Jul 4;7:73. Přejít k původnímu zdroji... Přejít na PubMed...
    31. Salleras L, Domínguez A, Bruguera M, Plans P, Costa J, Cardeñosa N, et al. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination. Vaccine. 2007 Dec 17;25(52):8726-31. Přejít k původnímu zdroji... Přejít na PubMed...
    32. Němeček V, Částková J, Fritz P, Linhartová A, Švandová E, Šrámová H, et al. The 2001 serological survey in the Czech Republic - viral hepatitis. Cent Eur J Public Health. 2003 Dec;11 Suppl:S54-61.
    33. Eurohep.net. Surveillance of vaccine preventable hepatitis [Internet]. CEV/ESOC; c2002 [cited 2014 Feb 25]. Available from: http://www.eurohep.net/.
    34. Gańczak M, Szych Z. Rationale against preoperative screening for HIV in Polish hospitals: a prevalence study of anti-HIV in contrast to antihepatitis C virus and hepatitis B surface antigen. Infect Control Hosp Epidemiol. 2009 Dec;30(12):1227-9. Přejít k původnímu zdroji... Přejít na PubMed...
    35. Baklaić Ž, Dečković-Vukres V, Kuzman M, editors. Croatian health service yearbook 2010 [Internet]. Zagreb: Croatian National Institute of Public Health; 2011 [cited 2013 Jul 2]. Available from: http://hzjz.hr/wp-centent/uploads/2013/11/ljetopis_2011.pdf.
    36. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol. 2005 Jul;76(3):327-32. Přejít k původnímu zdroji... Přejít na PubMed...
    37. Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Smira G, Regep L. The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey 2006 - 2008. J Gastrointestin Liver Dis. 2010 Dec;19(4):373-9.

    Zpět na obsah